The authors compared the incidence of PCP to the incidence in 1665 patients at the Multicenter AIDS Cohort Study (MACS) [13] who were not on HAART and not receiving any prophylaxis against PCP with CD4 counts <200 cells/μL. This evidence concerns the gene CD4 and pneumocystosis.